Skip to main content
. 2017 Aug 14;8(40):68381–68392. doi: 10.18632/oncotarget.20266

Table 4. Multivariate analysis of relations between clinicopathological variables and overall survival.

Full model
Clinicopathological variables Total N Hazard Ratio p-value Lower 95% Upper 95%
SLC2A1 (GLUT1) 339 1.0043 0.9449 0.8881 1.1359
SLC2A2 (GLUT2) 0.9096 0.0299* 0.8351 0.9908
GENDER 0.8409 0.1936 0.5745 1.2310
AGE (continuous) 1.0096 0.1936 0.9952 1.0241
STAGE (I or II vs III or IV) 2.3301 < 0.001*** 1.6015 3.3918
Selected Model (using stepwise method)
Clinicopathological variables Total N Hazard Ratio p-value Lower 95% Upper 95%
SLC2A2 (GLUT2) 339 0.9097 0.0145* 0.8433 0.9814
AGE (continuous) 1.0105 0.1459 0.9964 1.0249
Stage (I or II vs III or IV) 2.3498 < 0.001*** 1.6154 3.4182